PVI
Pura Vida Investments’s KalVista Pharmaceuticals KALV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-732,702
| Closed | -$4.95M | – | 98 |
|
2022
Q4 | $4.95M | Sell |
732,702
-100,000
| -12% | -$676K | 0.26% | 34 |
|
2022
Q3 | $12.1M | Buy |
832,702
+19,874
| +2% | +$288K | 0.7% | 16 |
|
2022
Q2 | $8M | Buy |
812,828
+771,435
| +1,864% | +$7.59M | 0.46% | 21 |
|
2022
Q1 | $610K | Buy |
41,393
+306
| +0.7% | +$4.51K | 0.02% | 92 |
|
2021
Q4 | $544K | Buy |
41,087
+19,139
| +87% | +$253K | 0.02% | 118 |
|
2021
Q3 | $383K | Buy |
21,948
+1,992
| +10% | +$34.8K | 0.01% | 148 |
|
2021
Q2 | $478K | Sell |
19,956
-301
| -1% | -$7.21K | 0.01% | 134 |
|
2021
Q1 | $520K | Buy |
+20,257
| New | +$520K | 0.01% | 140 |
|
2016
Q1 | – | Sell |
-80,000
| Closed | -$290K | – | 79 |
|
2015
Q4 | $290K | Hold |
80,000
| – | – | 0.12% | 53 |
|
2015
Q3 | $286K | Buy |
80,000
+40,000
| +100% | +$143K | 0.16% | 54 |
|
2015
Q2 | $276K | Buy |
+40,000
| New | +$276K | 0.14% | 54 |
|